Inventor · disambiguated record
Wei Wu
Also filed as: WU WEI · WU WEI-HSIU
12 granted patents·17 pending applications·37 citations·filing 2003–2025
87Inventor score
Top patents by PatentIndex Score
29 records- 0183US11577090B2Machine learning based artifact rejection for transcranial magnetic stimulation electroencephalogramUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted Feb 14, 2023·8 cites·35 claims
- 0282US11324963B2Brain stimulation treatment in depressionUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted May 10, 2022·7 cites·22 claims
- 0381US12383196B2Treatment of depression using machine learningUNIV LELAND STANFORD JUNIOR·Filed 2019·Granted Aug 12, 2025·3 cites·17 claims
- 0478US12490933B2Treatment of depression using machine learningUNIV LELAND STANFORD JUNIOR·Filed 2025·Granted Dec 9, 2025·0 cites·17 claims
- 0578US12233059B2Effective treatment of depression in patients having impaired learning and/or memory or certain EEG characteristics with a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2024·Granted Feb 25, 2025·0 cites·20 claims
- 0677US8215299B2Counter for metered dose inhalerWU WEI-HSIU·Filed 2010·Granted Jul 10, 2012·13 cites·6 claims
- 0776US2025185987A1Treatment of depression using machine learningUNIV LELAND STANFORD JUNIOR·Filed 2025·Application pending·0 cites
- 0876US2025185989A1Treatment of depression using machine learningUNIV LELAND STANFORD JUNIOR·Filed 2025·Application pending·0 cites
- 0976US2025185988A1Treatment of depression using machine learningUNIV LELAND STANFORD JUNIOR·Filed 2025·Application pending·0 cites
- 1075US12208096B2Effective treatment of depression in patients having impaired learning and/or memory or certain EEG characteristics with a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2024·Granted Jan 28, 2025·0 cites·12 claims
- 1172US12226375B1Method of treatment and selection of patients benefiting from agomelatine based on EEG measurementsALTO NEUROSCIENCE INC·Filed 2024·Granted Feb 18, 2025·0 cites·17 claims
- 1270US2025009738A1Effective treatment of depression in patients having impaired learning and/or memory or certain eeg characteristics with a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2024·Application pending·0 cites
- 1369US2024307377A1Method of treatment of depressed patients with poor cognition and selection of other patients benefiting from a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2024·Application pending·0 cites
- 1466US12115383B2Brain stimulation treatment in depressionUNIV LELAND STANFORD JUNIOR·Filed 2022·Granted Oct 15, 2024·0 cites·22 claims
- 1565US9241904B1Method for preparing metered dose sprayed inhaler for treating respiratory diseaseWU WEI-HSIU·Filed 2012·Granted Jan 26, 2016·1 cites·16 claims
- 1664US2024307376A1Method of treatment of depressed patients with poor cognition and selection of other patients benefiting from a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2024·Application pending·0 cites
- 1763US2024316016A1Effective treatment of depression in patients having impaired learning and/or memory or certain eeg characteristics with a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2024·Application pending·0 cites
- 1862US2025120957A1Treatment of neuropsychiatric disorders with tilivapramALTO NEUROSCIENCE INC·Filed 2024·Application pending·0 cites
- 1961US2024342165A1Method of treatment of depressed patients with poor cognition and selection of other patients benefiting from a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2024·Application pending·0 cites
- 2061US2024307378A1Effective treatment of depression in patients having impaired learning and/or memory or certain eeg characteristics with a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2024·Application pending·0 cites
- 2159US2024197721A1Effective treatment of depression in patients having impaired learning and/or memory or certain eeg characteristics with a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2023·Application pending·0 cites
- 2258US2024342164A1Method of treatment of depressed patients with poor cognition and selection of other patients benefiting from a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2024·Application pending·0 cites
- 2358US2025177387A1Effective treatment of depression in patients having impaired learning and/or memory or certain eeg characteristics with a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2025·Application pending·0 cites
- 2455US2025177386A1Method of treatment of depressed patients with poor cognition and selection of other patients benefiting from a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2025·Application pending·0 cites
- 2554US2022387424A1Method of treatment of depressed patients with poor cognition and selection of other patients benefiting from a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2022·Application pending·0 cites
- 2652US8877740B2Compound composition for inhalation used for treating asthmaWU WEI-HSIU·Filed 2011·Granted Nov 4, 2014·0 cites·8 claims
- 2752US2025177331A1Method of treatment and selection of patients benefiting from agomelatine based on eeg measurementsALTO NEUROSCIENCE INC·Filed 2025·Application pending·0 cites
- 2850US2003235600A1Cosmetic compositions comprising at least one polyester and at least one polyheteroatomOREAL·Filed 2003·Application pending·0 cites
- 2945USD838835SInhalerINTECH BIOPHARM LTD·Filed 2017·Granted Jan 22, 2019·5 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Wei Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →